Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2019 / Cilt: 25 - Sayı: 2

An Evaluation of the Effect of a One or Two-Step Gestational Diabetes Mellitus Screening Program on Obstetric and Neonatal Outcomes in Pregnancies

Pages
62–66
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: The study results showed a significantly higher rate of gestational diabetes mellitus di- agnosis for the pregnant women screened with the one-step screening program than the two-step screen- ing program.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: The aim of this study was to compare the obstetric and neonatal outcomes of pregnant women who were screened with one or two-step screening programs for diagnosis of gestational dia- betes mellitus.
📊
Key Findings & Data:STUDY DESIGN: A retrospective evaluation was made of pregnant women who were screened with one step [75 g oral glucose tolerance test] or two-step screening programs [50 g oral glucose challenge test and 100 g oral glucose tolerance test] depending on the preference of the physician between September 2016 and August 2017.
💡
Conclusion & Impact:CONCLUSION: The study results showed a significantly higher rate of gestational diabetes mellitus di- agnosis for the pregnant women screened with the one-step screening program than the two-step screen- ing program.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: The aim of this study was to compare the obstetric and neonatal outcomes of pregnant women who were screened with one or two-step screening programs for diagnosis of gestational dia- betes mellitus. STUDY DESIGN: A retrospective evaluation was made of pregnant women who were screened with one step [75 g oral glucose tolerance test] or two-step screening programs [50 g oral glucose challenge test and 100 g oral glucose tolerance test] depending on the preference of the physician between September 2016 and August 2017. RESULTS: The one-step screening program was applied to 34.1% (n:1358) of the pregnancies and the remaining 65.9% (n=2623) were screened using the two-step program. The following results were ob- tained for the pregnant women applied with the one and two-step screening programs, respectively; mean age: 29.37 ± 7.6 years and 28.1 ± 6.2 years, gestational diabetes mellitus: 8.8% and 4.8%, pre- term birth: 5.2% and 6.9%, term birth: 89.8% and 85.5%, postterm birth: 5% and 7.6%, vaginal delivery: 74.8% and 67.5%, caesarean section delivery: 25.2% and 32.5%, birth weight: 3389 ± 432 g and 3234.1 ± 415.9 g, and mean 5-minute APGAR score: 9.1 ± 0.4 and 9.2 ± 0.7. Comparisons showed statistically significant differences between the groups. CONCLUSION: The study results showed a significantly higher rate of gestational diabetes mellitus di- agnosis for the pregnant women screened with the one-step screening program than the two-step screen- ing program. Although the mean maternal age was significantly higher in the pregnant women screened with the one-step screening program, these pregnancies were observed to have better outcomes (low rates of preterm birth, postterm birth, caesarean delivery and high rates of term birth, vaginal delivery). These results can be attributed to the early referral to a treatment program and follow-up, even though more cases of gestational diabetes mellitus were diagnosed with the one-step screening program.

🔖

Cite This Article

AKGÖL, S., OBUT, M., BAGLI, I., KAHVECI, B., BUDAK, M. Ş. (2019). An Evaluation of the Effect of a One or Two-Step Gestational Diabetes Mellitus Screening Program on Obstetric and Neonatal Outcomes in Pregnancies. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 25 - Sayı: 2, 62–66. https://ajindex.com/articles/160458

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommen- dations of the Fifth International Workshop -Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30 (Supplement): 251-60. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2011;34(1):11-61. Moses RG. The recurrence rate of gestational diabetes in subsequent pregnancies. Diabetes Care. 1996;19(12): 1348-50. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2010;33(1):11-61.
  2. Casey BM, Lucas MJ, Mcintire, DD, Leveno KJ. Pregnacy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol. 1997;90(6):869-73.
  3. Di Cianni G, Volpe L, Casadidio I, Bottone P, Marselli L, Lencioni C, et al. Universal screening and intensive meta- bolic management of gestational diabetes: cost-effective- ness in Italy. Acta Diabetol. 2002;39(2):69-73. Kitzmiller JL. Cost analysis of diagnosis and treatment of gestational diabetes. Clin Obstet Gynecol. 2000;43(1):140-53. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33(3):676-82. Committee on Practice. Bulletins-Obstetrics. Practice Bulletin No. 137 Gestational diabetes mellitus. Obstet Gynecol 2013;122(2 Pt 1):406-16.
  4. Agarwal MM, Dhatt GS, Punnose J, Koster G. Gestational diabetes: dilemma caused by multiple international diag- nostic criteria. Diabet Med. 2005;22(12):1731-36. WHO 2013. Diagnostic Criteria and Classification of Hyper glycaemia First Detected in Pregnancy. Available online at: http://apps.who.int/iris/bitstream/10665/85975/ 1/WHO_NMH_MND_13.2_eng.pdf (Accessed February, 25,2017).
  5. Hod M, Kapur A, Sacks DA, Hadar E, Agarwal M, Di Ren zo GC, et al. The International Federation of Gyne cology and Obstetrics (FIGO) Initiative on gestational dia- betes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131 (Suppl 3): S173-211. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care 2017;40(Suppl) 1:11-24
  6. Meltzer SJ, Snyder J, Penrod JR, Nudi M, Morin L. Gesta - ti onal diabetes mellitus screening and diagnosis:a pros pective randomised controlled trial c